Delivery Order 75F40124D00044-75F40126F19002

The Food and Drug Administration issued a delivery order to The Lewin Group, Inc. on September 30, 2026, under the CBER BEST Initiative 3 – Data Sources for Surveillance of Biologics IDIQ with a ceiling value of $7,845,975 for health care data sources for surveillance of biologics, with ultimate completion on September 29, 2027.

The BEST Initiative 3 is an FDA multiple-award contract with a $75 million ceiling supporting longitudinal healthcare data access and surveillance of biologics. This delivery order carries Time and Materials pricing. Place of performance is La Crosse, WI. The Lewin Group is a health care and human services consulting firm subsidiary of UnitedHealth Group, competing in full and open competition across federal health agencies; the firm operates primarily as a prime contractor with minimal subcontract exposure and brings health care data, claims analytics, and health outcomes research capabilities to federal evidence-building and innovation-assessment work.